(662)-236-2609


Research
ELI has successfully executed research projects for federal and private organizations ranging from inception of concept to product development and patent. In addition, ELI participates in product testing, pharmacokinetic studies, stability studies, and method development for a wide range of clients. The selected patents listed below show the diversity of research projects performed at ELI:

  • Salamone, Salvatore J.; Courtney, Jodi B.; Stocker, Dennis; ElSohly, Mahmoud A.; Gul, Waseem; Taxol Immunoassay, U.S. Patent 7,175,993 B2, issued February 13, 2007.
  • ElSohly, Mahmoud A.; Ross, Samir A.; Galal, Ahmed M.; Dihydroartemisinin and Dihydroartemisitene Dimers as Anti-Cancer and Anti-Infective Agents, U.S. Patent 7,098,242, issued August 29, 2006
  • Elsohly, Mahmoud A.; Gul, Waseem; Anticancer and Antiprotozoal Dihydroartemisinin and Dihydroartemisitene Dimers with Desirable Chemical Functionalities, European Patent WO 2006/002105 A1, issued January 5, 2006.
  • ElSohly, Mahmoud A.; Ross, Samir A., Galal, Ahmed M.; Dihydroartemisinin and Dihydroartemisitene Dimers as Anti-Cancer and Anti-Infective Agents, U.S. Patent 6,790,863 B2, issued September 14, 2004.
  • Pasco, David; Pugh, Nirmal; Ross, Samir A.; ElSohly, Mahmoud A.; Potent Immunostimulants from Micro-Algae, South Aftican Patent No. 2003/1050, issued July 28, 2004, New Zealand Patent No. 523695, issued November 11, 2004.
  • ElSohly, Mahmoud A.; Samir Ross; and Shixia Feng; Method of Preparing delta-9-tetrahydrocannabinol esters, Australia Patent No. 770382, issued June 17, 2004.
  • ElSohly, Mahmoud A.; Samir Ross; Method of preparing delta-9-tetrahydrocannabinol, Australia Patent No. 763700, issued November 13, 2003.
  • ElSohly, Mahmoud A.; Samir Ross; Method of preparing delta-9-tetrahydrocannabinol, U.S. Patent 6,365,416 B1, issued April 2, 2002.
  • ElSohly, Mahmoud A.; Samir Ross; and Shixia Feng; Method of Preparing delta-9-tetrahydrocannabinol esters, U.S. Patent 6,008,383, issued December 28, 1999.
  • ElSohly, Mahmoud A.; Stable Suppository Formulations Effecting Bioavailability of Delta-9-THC, U.S. Patent 5,509,037 issued April 16, 1996.
  • ElSohly, Mahmoud A.; and R. Brenneisen, Method of Identifying Country of Origin of Cannabis, U.S. Patent 5,252,490, issued October 12, 1993,
  • ElSohly, Mahmoud A.; and Thomas L. Little, Jr., Deuterated Cannabinoids as Standards for the Analysis of Tetrahydrocannabinol and its Metabolites in Biological Fluids, U.S. Patent 4,036,014, issued July 30, 1991.
Staff members at ELI have established expertise in the areas of analysis of a variety of drugs and their metabolites including but not limited to marijuana and Cannabinoids, coca (leaves, paste, and cocaine), opiates, barbiturates, amphetamines, phencyclidine, benzodiazepines (including flunitrazepam), gamma hydroxybutyrate, and other drugs of abuse.

Technical staff members are well trained and have participated in the execution of a variety of research projects in the drug abuse area. Every member of the ELI team is cognizant of the importance and implications of drug testing and research, the forensic aspects of it, and the confidentiality of the test results.

ElSohly Laboratories Financial Conflict of Interest (FCOI) Policy:
eli_fcoi_policy.pdf